Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.20
GB's Cash to Debt is ranked lower than
51% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. GB: 0.20 )
GB' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.2

Equity to Asset 0.64
GB's Equity to Asset is ranked higher than
72% of the 373 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. GB: 0.64 )
GB' s 10-Year Equity to Asset Range
Min: 0.28   Max: 0.75
Current: 0.64

0.28
0.75
Interest Coverage 5.45
GB's Interest Coverage is ranked lower than
54% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 155.33 vs. GB: 5.45 )
GB' s 10-Year Interest Coverage Range
Min: 0.05   Max: 9.31
Current: 5.45

0.05
9.31
F-Score: 8
Z-Score: 3.61
M-Score: -2.60
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.41
GB's Operating margin (%) is ranked higher than
82% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 6.29 vs. GB: 10.41 )
GB' s 10-Year Operating margin (%) Range
Min: 0.2   Max: 17.66
Current: 10.41

0.2
17.66
Net-margin (%) 6.97
GB's Net-margin (%) is ranked higher than
80% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 5.11 vs. GB: 6.97 )
GB' s 10-Year Net-margin (%) Range
Min: -2.87   Max: 10.76
Current: 6.97

-2.87
10.76
ROE (%) 8.85
GB's ROE (%) is ranked higher than
79% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 5.84 vs. GB: 8.85 )
GB' s 10-Year ROE (%) Range
Min: -2.46   Max: 10.53
Current: 8.85

-2.46
10.53
ROA (%) 5.38
GB's ROA (%) is ranked higher than
80% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 3.49 vs. GB: 5.38 )
GB' s 10-Year ROA (%) Range
Min: -1.07   Max: 6.21
Current: 5.38

-1.07
6.21
ROC (Joel Greenblatt) (%) 22.44
GB's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 12.42 vs. GB: 22.44 )
GB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.38   Max: 52.65
Current: 22.44

0.38
52.65
Revenue Growth (%) 5.40
GB's Revenue Growth (%) is ranked higher than
73% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. GB: 5.40 )
GB' s 10-Year Revenue Growth (%) Range
Min: 0.2   Max: 30.3
Current: 5.4

0.2
30.3
EBITDA Growth (%) -4.50
GB's EBITDA Growth (%) is ranked higher than
73% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: -2.40 vs. GB: -4.50 )
GB' s 10-Year EBITDA Growth (%) Range
Min: -7.6   Max: 30.6
Current: -4.5

-7.6
30.6
EPS Growth (%) 1.00
GB's EPS Growth (%) is ranked higher than
75% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. GB: 1.00 )
GB' s 10-Year EPS Growth (%) Range
Min: -20   Max: 146.6
Current: 1

-20
146.6
» GB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

GB Guru Trades in Q3 2013

Jim Simons 9,500 sh (New)
Paul Tudor Jones 20,400 sh (New)
Steven Cohen 10,815 sh (New)
Diamond Hill Capital 623,135 sh (+5.52%)
Mario Gabelli 277,600 sh (-3.31%)
Chuck Royce 82,000 sh (-54.06%)
» More
Q4 2013

GB Guru Trades in Q4 2013

Steven Cohen 201,440 sh (+1762.6%)
Jim Simons 23,100 sh (+143.16%)
Chuck Royce 83,000 sh (+1.22%)
Paul Tudor Jones Sold Out
Diamond Hill Capital 614,570 sh (-1.37%)
Mario Gabelli 250,600 sh (-9.73%)
» More
Q1 2014

GB Guru Trades in Q1 2014

Joel Greenblatt 138,990 sh (New)
Jim Simons 112,290 sh (+386.1%)
Steven Cohen Sold Out
Mario Gabelli 243,600 sh (-2.79%)
Chuck Royce 70,000 sh (-15.66%)
Diamond Hill Capital 504,785 sh (-17.86%)
» More
Q2 2014

GB Guru Trades in Q2 2014

Joel Greenblatt 250,635 sh (+80.33%)
Chuck Royce 107,000 sh (+52.86%)
Jim Simons 161,300 sh (+43.65%)
Mario Gabelli 227,100 sh (-6.77%)
Diamond Hill Capital 414,221 sh (-17.94%)
» More
» Details

Insider Trades

Latest Guru Trades with GB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Add 80.33%0.07%$44.4 - $49.94 $ 42.6-9%250635
Joel Greenblatt 2014-03-31 New Buy0.1%$40.37 - $46.98 $ 42.6-3%138990
Joel Greenblatt 2012-06-30 Sold Out 0.09%$20.5 - $24.73 $ 42.692%0
Joel Greenblatt 2012-03-31 Reduce -22.75%0.03%$21.51 - $25.49 $ 42.691%41455
Mario Gabelli 2012-03-31 Add 53.3%0.02%$21.51 - $25.49 $ 42.691%320400
Joel Greenblatt 2011-12-31 Add 21.58%0.02%$18.86 - $22.74 $ 42.6103%53665
Joel Greenblatt 2011-09-30 Add 49.86%0.05%$19.19 - $28.2 $ 42.685%44139
Joel Greenblatt 2011-06-30 Reduce -22.91%0.07%$25.32 - $28.95 $ 42.658%29453
Mario Gabelli 2011-06-30 Add 40.27%0.01%$25.32 - $28.95 $ 42.658%209000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.90
GB's P/E(ttm) is ranked higher than
85% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 55.30 vs. GB: 23.90 )
GB' s 10-Year P/E(ttm) Range
Min: 11.04   Max: 575.08
Current: 23.9

11.04
575.08
P/B 1.85
GB's P/B is ranked higher than
83% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. GB: 1.85 )
GB' s 10-Year P/B Range
Min: 0.97   Max: 3.95
Current: 1.85

0.97
3.95
P/S 1.58
GB's P/S is ranked higher than
81% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. GB: 1.58 )
GB' s 10-Year P/S Range
Min: 0.78   Max: 4.47
Current: 1.58

0.78
4.47
PFCF 20.58
GB's PFCF is ranked higher than
91% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 20.58 )
GB' s 10-Year PFCF Range
Min: 6.12   Max: 169.91
Current: 20.58

6.12
169.91
EV-to-EBIT 17.55
GB's EV-to-EBIT is ranked higher than
87% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 37.22 vs. GB: 17.55 )
GB' s 10-Year EV-to-EBIT Range
Min: 8.3   Max: 3207.3
Current: 17.55

8.3
3207.3
PEG 2.95
GB's PEG is ranked higher than
92% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 2.95 )
GB' s 10-Year PEG Range
Min: 0.71   Max: 920.69
Current: 2.95

0.71
920.69
Shiller P/E 48.70
GB's Shiller P/E is ranked higher than
85% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 48.70 )
GB' s 10-Year Shiller P/E Range
Min: 22.95   Max: 61.71
Current: 48.7

22.95
61.71
Current Ratio 4.07
GB's Current Ratio is ranked higher than
82% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. GB: 4.07 )
GB' s 10-Year Current Ratio Range
Min: 1.6   Max: 8.42
Current: 4.07

1.6
8.42
Quick Ratio 2.38
GB's Quick Ratio is ranked higher than
76% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. GB: 2.38 )
GB' s 10-Year Quick Ratio Range
Min: 0.79   Max: 6.93
Current: 2.38

0.79
6.93

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 8.30
GB's Price/Tangible Book is ranked higher than
61% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 5.89 vs. GB: 8.30 )
GB' s 10-Year Price/Tangible Book Range
Min: 5.43   Max: 74.81
Current: 8.3

5.43
74.81
Price/DCF (Projected) 1.26
GB's Price/DCF (Projected) is ranked higher than
92% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 17.20 vs. GB: 1.26 )
GB' s 10-Year Price/DCF (Projected) Range
Min: 0.52   Max: 1.66
Current: 1.26

0.52
1.66
Price/Median PS Value 1.20
GB's Price/Median PS Value is ranked higher than
68% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 1.15 vs. GB: 1.20 )
GB' s 10-Year Price/Median PS Value Range
Min: 0.61   Max: 4.02
Current: 1.2

0.61
4.02
Price/Graham Number 2.92
GB's Price/Graham Number is ranked higher than
80% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 6.47 vs. GB: 2.92 )
GB' s 10-Year Price/Graham Number Range
Min: 1.97   Max: 14.44
Current: 2.92

1.97
14.44
Earnings Yield (Greenblatt) 5.70
GB's Earnings Yield (Greenblatt) is ranked higher than
81% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. GB: 5.70 )
GB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 12
Current: 5.7

0.1
12
Forward Rate of Return (Yacktman) 8.10
GB's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.34 vs. GB: 8.10 )
GB' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.1   Max: 25.5
Current: 8.1

3.1
25.5

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WGB.Germany
Greatbatch, Inc is a Delaware corporation was incorporated in 1997. The Company is a developer and manufacturer of critical products used in medical devices for the cardiac rhythm management, neuromodulation, vascular, orthopedic and interventional radiology markets. Its two reportable segments are Greatbatch Medical and Electrochem Solution. The Greatbatch Medical segment designs and manufactures medical devices and components primarily for the Cardiac Rhythm Management, Neuromodulation, Vascular Access and Orthopaedic markets. Additionally, Greatbatch Medical offers assembly and design engineering services for products that incorporate Greatbatch Medical components. Greatbatch Medical also offers its customers complete medical devices including design, development, manufacturing, regulatory submission and supporting worldwide distribution. Electrochem provides technology solutions where safety, reliability, quality and durability are critical. Electrochem's customized primary (non-rechargeable) and secondary (rechargeable) battery solutions are used in markets such as energy, portable medical, military, environmental and more. Electrochem's product lines cover a number of highly-customized battery-powered applications in remote and demanding environments, including down hole drilling tools, military communication devices, automated external defibrillators, oceanographic buoys and more. Electrochem's primary and secondary power solutions and wireless sensing systems are used in markets where failure is not an option. Electrochem's product designs incorporate protective circuitry, glass-to-metal hermetic seals, fuses and diodes to help ensure safe, durable and reliable power as devices are subjected to these harsh conditions. Its secondary power solutions comprise a number of chemistries including lithium, nickel and lead acid. These solutions also provide value-adds that complement each power source, including engineering design expertise, advanced electronics, smart charging and battery management systems, to ensure each solution is ready to perform in mission critical and life-saving applications. Products from its Greatbatch Medical business are sold directly to its customers. In its Electrochem business, the Company utilizes a combination of direct and indirect sales methods, depending on the particular product. Greatbatch Medical customers include large multi-national OEMs and their affiliated subsidiaries such as, Biotronik, Boston Scientific, Johnson & Johnson, Medtronic, Smith & Nephew, Sorin Group, St. Jude Medical, Stryker and Zimmer. Electrochem customers include General Electric, Halliburton Company, Scripps Institution of Oceanography, Thales, Weatherford International and Zoll Medical Corp. The main raw materials used in the Company's business include lithium, iodine, tantalum, platinum, ruthenium, gallium trichloride, tantalum pellets, vanadium pentoxide, iridium, and titanium. Existing and potential competitors i

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK